Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7522701 | 0.76 | CYP2B6 (0.34) | — | |
| SCHEMBL15730445 | 0.76 | ADRB1 (0.33) | ADRB1 | |
| SCHEMBL467885 | 0.75 | ADRB1 (0.31) | ADRB1 | |
| SCHEMBL9363442 | 0.75 | ADRB1 (0.31) | ADRB1 | |
| SCHEMBL8078414 | 0.75 | ADRB1 (0.31) | ADRB1 | |
| SCHEMBL7965808 | 0.74 | — | — | |
| SCHEMBL8078553 | 0.73 | — | — | |
| SCHEMBL9184477 | 0.72 | — | — | |
| SCHEMBL812845 | 0.71 | OPRD1 (0.32) | — | |
| SCHEMBL11813848 | 0.71 | CHRM5 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118893079-A | Recovery method of polyester/wool blended fabric | 青岛阿脒诺材料技术有限公司 | 2024-11-05 | — | — | CN | claimed |
| CN-118480206-A | Preparation method of high-resilience polyurethane microporous elastomer backing plate for railway | 苏州智源颢联新材料科技有限公司 | 2024-08-13 | — | — | CN | claimed |
| EP-2314544-B1 | HIGHLY HEAT-RESISTANT BETA-ZEOLITE AND SCR CATALYST USING SAME | TOSOH CORP (JP) | 2023-06-28 | — | — | EP | claimed |
| US-9115156-B2 | Biodegradable phosphoester polyamines | COVIDIEN LP (US) | 2015-08-25 | — | — | US | claimed |
| EP-2809699-A1 | IMPROVED SHELF LIFE OF POLYOL BLENDS CONTAINING HALOGENATED OLEFINS BY ENCAPSULATION OF ACTIVE COMPONENTS | Arkema, Inc. (US) | 2014-12-10 | — | — | EP | claimed |
| US-20140051879-A1 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | COVIDIEN LP (US) | 2014-02-20 | — | — | US | claimed |
| WO-2013116416-A1 | IMPROVED SHELF LIFE OF POLYOL BLENDS CONTAINING HALOGENATED OLEFINS BY ENCAPSULATION OF ACTIVE COMPONENTS | ARKEMA INC. (US) | 2013-08-08 | — | — | WO | claimed |
| EP-1991161-B1 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | TYCO HEALTHCARE (US) | 2012-11-07 | — | — | EP | claimed |
| EP-1991161-A2 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | Tyco Healthcare Group, LP (US) | 2008-11-19 | — | — | EP | claimed |
| US-20080279807-A1 | Biodegradable Phosphoester Polyamines | COVIDIEN LP | 2008-11-13 | — | — | US | claimed |
| WO-2007100574-A2 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | TYCO HEALTHCARE GROUP LP (US) | 2007-09-07 | — | — | WO | claimed |
| EP-0322801-B1 | Preparation of fine-cell rigid polyurethane foam using amine catalyst | TOSOH CORP (JP) | 1994-11-02 | — | — | EP | claimed |
| US-5006501-A | Retarding effect; mixture containing triethylenediamine | TOSOH CORPORATION (JP) | 1991-04-09 | — | — | US | claimed |
| US-4910230-A | Reacting a polyol, blowing agent, polyisocyanate in presence amine catalyst | TOSOH CORPORATION (JP) | 1990-03-20 | — | — | US | claimed |
| EP-0322801-A2 | Preparation of fine-cell rigid polyurethane foam using amine catalyst | Tosoh Corporation (JP) | 1989-07-05 | — | — | EP | claimed |
| US-4587273-A | POLYETHERURETHANE COPOLYMER | IKEDA BUSSAN CO., LTD. (JP) | 1986-05-06 | — | — | US | claimed |
| JP-1190716-A | — | — | None | — | — | JP | disclosed |
| JP-6179735-A | — | — | None | — | — | JP | disclosed |
| US-3933701-A | High resilience polyurethane foam | OLIN CORPORATION (US) | 1976-01-20 | — | — | US | disclosed |
| US-3931066-A | HIGH RESILIENCE POLYURETHANE FOAM | OLIN CORPORATION (US) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080279807-A1 | Biodegradable Phosphoester Polyamines | PHOSPHO1, SRM, SGMS1 | ADRB1 4025/4885 |
| US-20140051879-A1 | BIODEGRADABLE PHOSPHOESTER POLYAMINES | PHOSPHO1, SRM, SGMS1 | ADRB1 4025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.